Favorable event free-survival of high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for higher risk diffuse large B-cell lymphoma in first complete remission

Favorable event free-survival of high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for higher risk diffuse large B-cell lymphoma in first complete remission

High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) has been applied to patients with diffuse large B-cell lymphoma (DLBCL); it is well established that ASCT shows significant survival benefits for chemosensitive relapse. However, half of relapsed patients are resistant to...

Full description

Bibliographic Details
Main Authors: Hiroto Kaneko, Yasuhiko Tsutsumi, Takahiro Fujino, Saeko Kuwahara, Muneo Ohshiro, Toshiki Iwai, Junya Kuroda, Shouhei Yokota, Shigeo Horiike, Masafumi Taniwaki
Format: Article
Language:English
Published: PAGEPress Publications 2015-06-01
Series:Hematology Reports
Subjects:
Diffuse large B-cell lymphoma
autologous transplantation
upfront
Online Access:http://www.pagepress.org/journals/index.php/hr/article/view/5812

Internet

http://www.pagepress.org/journals/index.php/hr/article/view/5812

Similar Items